Peru faces significant challenges in achieving equitable and timely oncology care. Cancer ranks among the leading causes of death, with many patients diagnosed at advanced stages. Access to quality medicines remains uneven, especially outside major urban centers. Shortages, quality concerns with imports, long waiting times, and high costs continue to hinder treatment continuity. In this